| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |